Keyword: Trelegy Ellipta

Breztri Aerosphere, AZ's three-in-one COPD inhaler, just won its first global nod to rival GlaxoSmithKline's Trelegy Ellipta.

A handful of branded drug ads are using popular ‘70s light rock songs, both to aid recall and to reach older audiences with music from their youth.

GSK has data in hand that could help Trelegy move into the asthma arena—though it's not all positive.

Boehringer Ingelheim’s ad campaign for Ofev pulled away from GlaxoSmithKline’s Trelegy to land the #FierceMadness ad tournament crown.

The #FierceMadness final game is set—and it’ll be GlaxoSmithKline's Trelegy taking on Boehringer Ingelheim's Ofev for the 2019 title.

#FierceMadness DTC is down to Repatha versus Trelegy, while Aimovig will take on Ofev in a short round of voting that ends Tuesday at midnight.

GSK expects sales of its pharma business to decline in 2019 thanks to the launch of Mylan's generic Advair.

GlaxoSmithKline continues to plow money into upgrading respiratory drug production, with the latest an expansion in Scotland to make APIs for inhalers.

GlaxoSmithKline spins the first ad campaign for key COPD drug Trelegy Ellipta this week, backed with a throwback soundtrack.